Nomura Holdings’s Ginkgo Bioworks DNA Stock Holding History

Nomura Holdings’s Portfolio DNA Stock Details DNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-2,500	Closed	-$1.15M	–	2292
2021 Q3	$1.15M	Buy	+2,500	New	+$1.22M	﹤0.01%	1074

Other funds holding DNA

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

ACG

Anchorage Capital Group New York $436M AUM 38.51% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Nomura Holdings's DNA Position: Q4 2023 in Review

Nomura Holdings sold out of Ginkgo Bioworks (DNA) in Q4 2023, closing a stake of 371 shares — an estimated $26.8K sold.

Nomura Holdings first reported a position in DNA in Q3 2021 and held it in 5 quarters. The position peaked at $1.15M in Q3 2021. 342 funds tracked by Wall St. Rank hold DNA as of Q4 2023.

Nomura Holdings reported no remaining Ginkgo Bioworks position as of Q4 2023 after selling out during the quarter.
Nomura Holdings sold 371 Ginkgo Bioworks shares in Q4 2023, an estimated $26.8K.
Nomura Holdings first reported a position in Ginkgo Bioworks in Q3 2021 and held it in 5 quarters.
Nomura Holdings's Ginkgo Bioworks position peaked at $1.15M in Q3 2021.
342 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q4 2023.

Based on Nomura Holdings's 13F filing for Q4 2023, filed 14 Feb 2024.